Abstract B091: Tandem chimeric antigne receptor T cell therapies for the treatment of pancreatic cancer
Chimeric antigen T cell therapy has entered into standard of care for hematologic malignancies such as B-ALL due to its robust efficacy. However, solid tumors such as pancreatic cancer pose challenges for CAR T cell therapies due to an immunosuppressive environment, antigen escape and tumor heterogeneity. As such...